NLSP logo

NLS Pharmaceutics AG (NLSP)

Profile

Full Name

NLS Pharmaceutics AG

Ticker Symbol

NLSP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Switzerland

IPO

January 29, 2021

Indexes

Not included

Website

http://nlspharma.com

Employees

6

Key Details

Price

$1.43(-4.67%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$12.80(+61.90% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.43
NLSP price is $1.43

30-Day Relative Volume

0.99
NLSP 30-day relative volume is 0.99

Price Performance

Price Most recent change

-4.67%
NLSP price was down -4.67% on Apr 16, 2025

Price YTD change

-32.23%
NLSP price is down -32.23% since January 1st

Price 1-year change

-73.12%
NLSP price is down -73.12% year-on-year

Price 3-year change

-96.56%
NLSP price is down -96.56% over the past 3 years

Price Range

Price All-time high

$234.00
NLSP price is currently -99.39% below its historical high of $234.00

Price 3-year low

$0.11
NLSP price is currently +1188.29% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$5.46M
NLSP market capitalization is $5.46 million

Market cap 3-year change

-67.67%
NLSP market capitalization is down -67.67% over the past 3 years

Market cap All-time high

$68.98M
NLSP market capitalization is currently -92.09% below its historical high of $68.98 million

Market cap sector rank

14.23%
NLSP market capitalization is higher than 14.23% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+252.27%
NLSP shares outstanding is up +252.27% year-on-year

Shares Outstanding 3-Year Change

+840.61%
NLSP shares outstanding is up +840.61% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.31
NLSP beta is 0.31

200-day SMA

$4.01
NLSP price is currently -64.30% below its 200-day simple moving average

50-day SMA

$1.71
NLSP price is currently -16.37% below its 50-day simple moving average

RSI

43.70
NLSP 14-day relative strength index is 43.70

Volume

0.99
NLSP 30-day relative volume is 0.99

ATR

$0.12
NLSP average true range is $0.12

10-day Historical Volatility

58.95%
NLSP 10-day historical volatility is 58.95%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
NLSP annual revenue value is unknown

Revenue Analysts estimate

-
NLSP annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
NLSP annual revenue 1-year change is unknown

Revenue Sector rank

-
NLSP annual revenue is unknown

EPS

EPS

-$12.80
NLSP annual earnings per share is -$12.80

EPS Analysts estimate

-$1.60
NLSP annual earnings per share is currently +700.00% higher than the consensus analysts' forecast

EPS 1-year change

+61.9%
NLSP annual earnings per share is up +61.9% year-on-year

EPS Sector rank

9.83%
NLSP annual earnings per share is higher than 9.83% of companies in Healthcare sector

Profit

Gross profit

-
NLSP annual gross profit value is unknown

Gross margin

-
NLSP annual gross profit margin value is unknown

Operating profit

-$11.81M
NLSP annual operating income is -$11.81 million

Operating margin

-
NLSP annual operating profit margin value is unknown

Net income

-$12.17M
NLSP annual net profit is -$12.17 million

Net margin

-
NLSP annual net profit margin value is unknown

Expenses

Total expenses

$11.81M
NLSP annual total expenses is $11.81 million

Operating expenses

$11.81M
NLSP annual total operating expenses is $11.81 million

Cost of goods sold

-
NLSP annual cost of goods sold value is unknown

Selling, general & administrative expenses

$5.90M
NLSP annual SGA is $5.90 million

Depreciation and amortization

$11.40K
NLSP annual depreciation & amortization is $11.40 thousand

Interest expense

$145.20K
NLSP annual interest expense is $145.20 thousand

Income tax

-
NLSP annual income tax value is unknown

EBIT & EBITDA

EBIT

-$12.03M
NLSP annual earnings before interest & taxes is -$12.03 million

EBITDA

-$12.02M
NLSP annual EBITDA is -$12.02 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.85M
NLSP annual total assets is $1.85 million

Non current assets

$23.60K
NLSP annual long term assets is $23.60 thousand

Current assets

$1.82M
NLSP annual total current assets is $1.82 million

Cash and cash equivalents

$897.70K
NLSP annual cash & cash equivalents is $897.70 thousand

Accounts receivable

-
NLSP annual accounts receivable value is unknown

Inventory

-
NLSP annual inventory value is unknown

Liabilities

Total liabilities

$10.68M
NLSP annual total liabilities is $10.68 million

Long term liabilities

$2.76M
NLSP annual total long term liabilities is $2.76 million

Current liabilities

$7.92M
NLSP annual total current liabilities is $7.92 million

Accounts payable

$4.63M
NLSP annual accounts payable is $4.63 million

Debt

Total debt

$1.63M
NLSP annual total debt is $1.63 million

Total debt 1-year change

+100%
NLSP annual total debt is up +100% year-on-year

Long term debt

-
NLSP annual long term debt value is unknown

Short term debt

$1.63M
NLSP annual short term debt is $1.63 million

Equity & Capital

Shareholders equity

-$8.83M
NLSP annual stockholders equity is -$8.83 million

Book value

-$8.83M
NLSP annual book value is -$8.83 million

Retained earnings

-$70.37M
NLSP annual retained earnings is -$70.37 million

Working capital

-$6.10M
NLSP annual working capital is -$6.10 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$9.68M
NLSP annual cash flow from operations is -$9.68 million

Cash from operations 1-year change

+30.22%
NLSP annual cash flow from operations is up +30.22% year-on-year

Cash from investing

$0.00
NLSP annual cash flow from investing activities is $0.00

Cash from investing 1-year change

0%
NLSP {parameterFullLabel} has remained unchanged year-on-year

Cash from financing

$1.63M
NLSP annual cash flow from financing activities is $1.63 million

Cash from financing 1-year change

-90.61%
NLSP annual cash flow from financing activities is down -90.61% year-on-year

CAPEX

CAPEX

-
NLSP annual capital expenditures value is unknown

CAPEX 1-year change

-
NLSP annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$9.68M
NLSP annual free cash flow is -$9.68 million

Free cash flow 1-year change

+30.22%
NLSP annual free cash flow is up +30.22% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
NLSP annual gross profit margin value is unknown

Operating margin

-
NLSP annual operating profit margin value is unknown

Net margin

-
NLSP annual net profit margin value is unknown

ROA & ROE

ROA

-659.16%
NLSP annual return on assets is -659.16%

ROE

137.79%
NLSP annual return on equity is 137.79%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NLSP price to earnings ratio value is unknown

PE ratio Sector rank

-
NLSP price to earnings ratio is unknown

PB Ratio

PB ratio

-0.59
NLSP price to book ratio is -0.59

PB ratio Sector rank

10.05%
NLSP price to book ratio is higher than 10.05% of companies in Healthcare sector

PS Ratio

PS ratio

-
NLSP price to sales ratio value is unknown

PS ratio Sector rank

-
NLSP price to sales ratio is unknown

Enterprise value

Enterprise value

$6.62M
NLSP enterprise value is $6.62 million

Enterprise value Sector rank

20.81%
NLSP enterprise value is higher than 20.81% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
NLSP EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
NLSP EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.23
NLSP annual current ratio is 0.23

Quick ratio

-
NLSP annual quick ratio value is unknown

Leverage

Debt to equity

-0.18
NLSP annual debt to equity ratio is -0.18

Interest coverage ratio

-82.83
NLSP annual interest coverage ratio is -82.83

Risk & Stability

Piotroski F-Score

-
NLSP piotroski f-score value is unknown

Altman Z-Score

-
NLSP altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 12, 21 Brookline Capital
Buy
Mar 3, 21 Maxim Group
Buy

Institutional Ownership

Similar stocks

TNON logo
Tenon Medical (TNON)
NCNA logo
NuCana (NCNA)
NAOV logo
NanoVibronix (NAOV)
ACON logo
Aclarion (ACON)
IBO logo
Impact BioMedical (IBO)
NKGN logo
NKGen Biotech (NKGN)
APM logo
Aptorum Group Limited (APM)
LMDX logo
LumiraDx Limited (LMDX)
CPHI logo
China Pharma Holdings (CPHI)
  • What is the ticker symbol for NLS Pharmaceutics AG?
  • Does NLS Pharmaceutics AG pay dividends?
  • What sector is NLS Pharmaceutics AG in?
  • What industry is NLS Pharmaceutics AG in?
  • What country is NLS Pharmaceutics AG based in?
  • When did NLS Pharmaceutics AG go public?
  • Is NLS Pharmaceutics AG in the S&P 500?
  • Is NLS Pharmaceutics AG in the NASDAQ 100?
  • Is NLS Pharmaceutics AG in the Dow Jones?
  • When was NLS Pharmaceutics AG's last earnings report?
  • When does NLS Pharmaceutics AG report earnings?
  • Should I buy NLS Pharmaceutics AG stock now?

What is the ticker symbol for NLS Pharmaceutics AG?

The ticker symbol for NLS Pharmaceutics AG is NASDAQ:NLSP

Does NLS Pharmaceutics AG pay dividends?

No, NLS Pharmaceutics AG does not pay dividends

What sector is NLS Pharmaceutics AG in?

NLS Pharmaceutics AG is in the Healthcare sector

What industry is NLS Pharmaceutics AG in?

NLS Pharmaceutics AG is in the Biotechnology industry

What country is NLS Pharmaceutics AG based in?

NLS Pharmaceutics AG is headquartered in Switzerland

When did NLS Pharmaceutics AG go public?

NLS Pharmaceutics AG's initial public offering (IPO) was on January 29, 2021

Is NLS Pharmaceutics AG in the S&P 500?

No, NLS Pharmaceutics AG is not included in the S&P 500 index

Is NLS Pharmaceutics AG in the NASDAQ 100?

No, NLS Pharmaceutics AG is not included in the NASDAQ 100 index

Is NLS Pharmaceutics AG in the Dow Jones?

No, NLS Pharmaceutics AG is not included in the Dow Jones index

When was NLS Pharmaceutics AG's last earnings report?

NLS Pharmaceutics AG's most recent earnings report was on Jan 10, 2024

When does NLS Pharmaceutics AG report earnings?

The date for NLS Pharmaceutics AG's next earnings report has not been announced yet

Should I buy NLS Pharmaceutics AG stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page